Administer seeks to continue growth investments as well as organic and inorganic growth in 2023. Administer estimates that its net sales will be EUR 75–77 million and its EBITDA margin will be 3–5% in 2023.

Administer has begun the implementation of the profitability programme. The company has also initiated strategy work and will set new long-term financial targets after its completion.